Top 5 Drug Type | Count |
---|---|
Small molecule drug | 15 |
Herbal medicine | 1 |
Probiotics | 1 |
Enzyme | 1 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date01 Sep 2009 |
Target |
Mechanism AChE inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. EU [+3] |
First Approval Date11 May 1998 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date15 Mar 1994 |
Start Date10 Dec 2022 |
Sponsor / Collaborator |
Start Date01 Dec 2021 |
Sponsor / Collaborator |
Start Date01 Sep 2021 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Trihexyphenidyl Hydrochloride ( mAChRs ) | Dyskinesias More | Approved |
Dihydrocodeine PhoSphate/dl-Methylephedrine Hydrochloride/Chlorpheniramine Maleate | Cough More | Approved |
Ferric Chloride/Manganese Chloride/Zinc Sulfate Hydrate/Cupric Sulfate/Potassium Iodide | Nutrition Disorders More | Approved |
Kallidinogenase(Towa Pharmaceutical) ( KNG1 ) | Menopausal syndrome More | Approved |
Ascorbic Acid/Calcium Pantothenate | Avitaminosis More | Approved |